GB201805951D0 - Pharmaceutical composition and method for manufacturing the same - Google Patents
Pharmaceutical composition and method for manufacturing the sameInfo
- Publication number
- GB201805951D0 GB201805951D0 GBGB1805951.9A GB201805951A GB201805951D0 GB 201805951 D0 GB201805951 D0 GB 201805951D0 GB 201805951 A GB201805951 A GB 201805951A GB 201805951 D0 GB201805951 D0 GB 201805951D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- manufacturing
- same
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1705745.6A GB2561355A (en) | 2017-04-10 | 2017-04-10 | Pharmaceutical composition and a method for manufacturing the same |
Publications (3)
Publication Number | Publication Date |
---|---|
GB201805951D0 true GB201805951D0 (en) | 2018-05-23 |
GB2564515A GB2564515A (en) | 2019-01-16 |
GB2564515B GB2564515B (en) | 2022-10-26 |
Family
ID=58744775
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1705745.6A Withdrawn GB2561355A (en) | 2017-04-10 | 2017-04-10 | Pharmaceutical composition and a method for manufacturing the same |
GB1805951.9A Active GB2564515B (en) | 2017-04-10 | 2018-04-10 | Pharmaceutical composition and a method for manufacturing the same |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1705745.6A Withdrawn GB2561355A (en) | 2017-04-10 | 2017-04-10 | Pharmaceutical composition and a method for manufacturing the same |
Country Status (1)
Country | Link |
---|---|
GB (2) | GB2561355A (en) |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4788220A (en) * | 1987-07-08 | 1988-11-29 | American Home Products Corporation (Del.) | Pediatric ibuprofen compositions |
JP4950063B2 (en) * | 2004-12-22 | 2012-06-13 | シェーリング コーポレイション | Pharmaceutical formulation |
US8999395B2 (en) * | 2007-02-09 | 2015-04-07 | Ceva Sante Animale | Pharmaceutical compositions for oral administration in the form of stabilised aqueous suspensions |
US20080260837A1 (en) * | 2007-04-20 | 2008-10-23 | Qpharma, L.L.C. | Physically stable aqueous suspensions of active pharmaceuticals |
US20100216754A1 (en) * | 2007-11-13 | 2010-08-26 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
JP2012533633A (en) * | 2009-07-20 | 2012-12-27 | ベテゲン・エルエルシー | Stable pharmaceutical omeprazole formulation for oral administration |
WO2013192066A1 (en) * | 2012-06-19 | 2013-12-27 | Intercontinental Great Brands Llc | Chewing gum product and method of production thereof |
BR102012030828A2 (en) * | 2012-12-03 | 2014-09-16 | Ems Sa | PHARMACEUTICAL COMPOSITION UNDERSTANDING DESLORATATIN AND PREDNISOLONE AND THEIR USE |
BR112015015439A2 (en) * | 2012-12-28 | 2017-07-11 | Otsuka Pharma Co Ltd | depot injectable formulation, process for producing a depot injectable formulation, and kit for prevention or treatment of polycystic kidney disease, use of a combination |
GB2513172A (en) * | 2013-04-18 | 2014-10-22 | Nupharm Lab Ltd | Liquid dosage form and delivery system |
US10174006B2 (en) * | 2013-06-06 | 2019-01-08 | Novartis Ag | Topical aqueous ophthalmic compositions containing a 1H-indole-1-carboxamide derivative and use thereof for treatment of ophthalmic disease |
CN104523589A (en) * | 2014-12-26 | 2015-04-22 | 万特制药(海南)有限公司 | Oral suspension type medicine composition containing agomelatine |
CN106474058B (en) * | 2015-08-31 | 2020-01-07 | 南京诺瑞特医药科技有限公司 | Injectable aripiprazole suspension formulations with extended shelf life |
-
2017
- 2017-04-10 GB GB1705745.6A patent/GB2561355A/en not_active Withdrawn
-
2018
- 2018-04-10 GB GB1805951.9A patent/GB2564515B/en active Active
Also Published As
Publication number | Publication date |
---|---|
GB2564515B (en) | 2022-10-26 |
GB201705745D0 (en) | 2017-05-24 |
GB2564515A (en) | 2019-01-16 |
GB2561355A (en) | 2018-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3364951A4 (en) | Nicotine composition for vaping devices and vaping devices employing the same | |
SG11202004253QA (en) | Oil-and-fat composition and manufacturing method thereof | |
IL266454B (en) | Implant and method for forming the implant | |
EP3254706A4 (en) | Deodorant and method for manufacturing same | |
EP3244262A4 (en) | Radiation-sensitive composition and pattern forming method | |
EP3586343A4 (en) | Titanium-molybdate and method for making the same | |
EP3590361A4 (en) | Luteolin-containing composition and method for manufacturing same | |
ZA201804964B (en) | Trabectedin-inclusive injectable pharmaceutical composition for gastrointestinal external use and method for manufacturing the same | |
HK1252116A1 (en) | Free-polyunsaturated-fatty-acid-containing composition and method for manufacturing same | |
EP3424521A4 (en) | Pharmaceutical composition and manufacturing method thereof | |
SG11201707046XA (en) | Gel composition and method for manufacturing same | |
SG11201605747PA (en) | Solid fat composition and method for manufacturing the same | |
PL3484782T3 (en) | Shelf-ready package and method for manufacturing the same | |
ZA201908090B (en) | Pharmaceutical composition and method for preparing same | |
LT3250188T (en) | Pharmaceutical composition comprising aprepitant and method for the preparation thereof | |
EP3590360A4 (en) | Lutein-containing composition and method for manufacturing same | |
EP3542143C0 (en) | Rheometer and method for the use thereof | |
GB201609412D0 (en) | Self-sanitising compositions and method for the production thereof | |
IL266938A (en) | Pharmaceutical preparation and method for its manufacture | |
EP3710099C0 (en) | Bioinductive patch and method for manufacturing the same | |
EP3563846A4 (en) | Pharmaceutical composition and method for producing same | |
PL3382775T3 (en) | Electrode unit and method for manufacturing the same | |
GB201805951D0 (en) | Pharmaceutical composition and method for manufacturing the same | |
GB201700337D0 (en) | Method and composition | |
EP3332745A4 (en) | Prosthesis component and method for the production thereof |